Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Pathogenicity and virulence of Crimean-Congo hemorrhagic fever virus: From enzootic maintenance to severe human disease.

Created on 06 Aug 2026

Authors

Virginia Aida-Ficken, Teresa E Sorvillo, Elif Karaaslan, Katherine A Davies, Éric Bergeron, Stephen R Welch, Jessica R Spengler

Published in

Virulence. Volume 17. Issue 1. Pages 2709250. Epub Aug 05, 2026.

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a severe tick-borne disease caused by Crimean-Congo hemorrhagic fever virus (CCHFV), an enveloped, negative-sense, tri-segmented RNA virus in the genus Orthonairovirus. The virus is endemic across Africa, the Middle East, Asia, and Europe, shaped by the ecology of ixodid ticks and their wildlife hosts. While infection in most vertebrates is asymptomatic, human disease ranges from mild illness to fulminant hemorrhagic fever with vascular leak, multiorgan failure, coagulopathy, and shock, with case-fatality rates up to 30% and no licensed countermeasures. This review synthesizes current understanding of CCHFV pathogenicity and virulence across its enzootic cycle. We highlight host and viral factors driving infection in ticks, intermediate hosts, and humans, including entry, immune evasion, and mechanisms underlying severe disease. We also identify key knowledge gaps and research priorities to advance understanding of CCHFV pathogenesis and inform strategies to mitigate severe disease.

PMID:
42555543
Bibliographic data and abstract were imported from PubMed on 06 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement